Table 3 Sensitive analyses of the association between UA trajectories and the risk of different events

Excluding participants with follow-up < 2 years (n = 64,296)

 Cardiac conduction block

Ref

1.30 (1.15–1.46)

1.86 (1.56–2.22)

 Atrioventricular block

Ref

1.40 (1.13–1.73)

2.96 (2.23–3.92)

 Bundle branch block

Ref

1.26 (1.09–1.46)

1.41 (1.12–1.78)

Excluding participants eGFR < 45 (mL/min/1.73m²) (n = 65,950)

 Cardiac conduction block

Ref

1.30 (1.15–1.46)

1.84 (1.54–2.19)

 Atrioventricular block

Ref

1.38 (1.11–1.70)

2.79 (2.10–3.70)

 Bundle branch block

Ref

1.27 (1.10–1.47)

1.43 (1.14–1.81)

Excluding participants with a history of gout (n = 66,565)

 Cardiac conduction block

Ref

1.30 (1.16–1.47)

1.82 (1.52–2.18)

 Atrioventricular block

Ref

1.39 (1.12–1.72)

2.87 (2.16–3.81)

 Bundle branch block

Ref

1.27 (1.10–1.47)

1.37 (1.08–1.73)

Excluding participants with UA data less than 4 times (n = 38,854)

 Cardiac conduction block

Ref

1.30 (1.11–1.52)

1.71 (1.36–2.16)

 Atrioventricular block

Ref

1.29 (0.98–1.71)

2.58 (1.80–3.70)

 Bundle branch block

Ref

1.30 (1.07–1.57)

1.31 (0.97–1.78)